EP1912630A4 - Compositions et procedes destines a reduire les douleurs postoperatoires - Google Patents

Compositions et procedes destines a reduire les douleurs postoperatoires

Info

Publication number: EP1912630A4
Authority: EP; European Patent Office
Prior art keywords: compositions; post; reduction; methods; operative pain
Prior art date: 2005-07-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP06788416A

Other languages

German (de)

English (en)

Other versions

EP1912630A2 (fr

Inventor

Richard L Kronenthal

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

ORTHOCON Inc

Original Assignee

ORTHOCON Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-25

Filing date

2006-07-25

Publication date

2012-10-03

2005-09-12 Priority claimed from US11/224,650 external-priority patent/US7955616B2/en

2006-07-25 Application filed by ORTHOCON Inc filed Critical ORTHOCON Inc

2008-04-23 Publication of EP1912630A2 publication Critical patent/EP1912630A2/fr

2012-10-03 Publication of EP1912630A4 publication Critical patent/EP1912630A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Physical Education & Sports Medicine (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Neurology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Materials Engineering (AREA)
Surgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP06788416A 2005-07-25 2006-07-25 Compositions et procedes destines a reduire les douleurs postoperatoires Withdrawn EP1912630A4 (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US70222605P	2005-07-25	2005-07-25
US11/224,650 US7955616B2 (en)	2003-09-23	2005-09-12	Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
US75830006P	2006-01-12	2006-01-12
PCT/US2006/028823 WO2007014210A2 (fr)	2005-07-25	2006-07-25	Compositions et procedes destines a reduire les douleurs postoperatoires

Publications (2)

Publication Number	Publication Date
EP1912630A2 EP1912630A2 (fr)	2008-04-23
EP1912630A4 true EP1912630A4 (fr)	2012-10-03

Family

ID=37683910

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP06788416A Withdrawn EP1912630A4 (fr)	2005-07-25	2006-07-25	Compositions et procedes destines a reduire les douleurs postoperatoires

Country Status (8)

Country	Link
EP (1)	EP1912630A4 (fr)
JP (1)	JP2009502928A (fr)
KR (1)	KR20080055782A (fr)
CN (1)	CN101484145A (fr)
AU (2)	AU2006272663C1 (fr)
CA (1)	CA2616384A1 (fr)
NZ (1)	NZ563557A (fr)
WO (1)	WO2007014210A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1856283A (zh)	2003-09-23	2006-11-01	奥斯治疗有限公司	生物可吸收的油灰样止血植入体
US8105628B2 (en)	2003-09-23	2012-01-31	Orthocon, Inc.	Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
US7955616B2 (en)	2003-09-23	2011-06-07	Orthocon, Inc.	Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
US8603528B2 (en)	2004-09-16	2013-12-10	Abyrx, Inc.	Compositions and method for the reduction of post-operative pain
US20110027331A1 (en) *	2009-07-29	2011-02-03	Warsaw Orthopedic, Inc.	An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation
HK1201213A1 (en) *	2011-10-28	2015-08-28	Baxter International Inc	Nonaqueous compositions for bone hemostasis, and methods for their use and manufacture
KR101852718B1 (ko) *	2017-04-04	2018-05-18	주식회사 제네웰	외과수술 후 절개부위 통증 감소를 위한 키트
CN112138203B (zh) *	2019-06-26	2022-11-08	陕西佰傲再生医学有限公司	骨止血材料

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6331313B1 (en) *	1999-10-22	2001-12-18	Oculex Pharmaceticals, Inc.	Controlled-release biocompatible ocular drug delivery implant devices and methods
US20020090398A1 (en) *	1999-11-16	2002-07-11	Atrix Laboratories, Inc.	Biodegradable polymer composition
US20030093157A1 (en) *	2001-06-29	2003-05-15	Casares Crisoforo Peralta	Biodegradable injectable implants and related methods of manufacture and use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4439420A (en) *	1982-11-16	1984-03-27	Ethicon, Inc.	Absorbable hemostatic composition
US4568536A (en) *	1985-02-08	1986-02-04	Ethicon, Inc.	Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US6992057B2 (en) *	2000-02-22	2006-01-31	The Procter & Gamble Company	Fatty acids, soaps, surfactant systems, and consumer products based thereon
US7112587B2 (en) *	2001-09-21	2006-09-26	Reddy Us Therapeutics, Inc.	Methods and compositions of novel triazine compounds
US8105628B2 (en) *	2003-09-23	2012-01-31	Orthocon, Inc.	Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects

2006
- 2006-07-25 KR KR1020087001952A patent/KR20080055782A/ko not_active Ceased
- 2006-07-25 EP EP06788416A patent/EP1912630A4/fr not_active Withdrawn
- 2006-07-25 CA CA002616384A patent/CA2616384A1/fr not_active Abandoned
- 2006-07-25 CN CNA2006800230204A patent/CN101484145A/zh active Pending
- 2006-07-25 JP JP2008524061A patent/JP2009502928A/ja active Pending
- 2006-07-25 NZ NZ563557A patent/NZ563557A/en not_active IP Right Cessation
- 2006-07-25 WO PCT/US2006/028823 patent/WO2007014210A2/fr not_active Ceased
- 2006-07-25 AU AU2006272663A patent/AU2006272663C1/en not_active Ceased
2011
- 2011-01-28 AU AU2011200355A patent/AU2011200355A1/en not_active Abandoned

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6331313B1 (en) *	1999-10-22	2001-12-18	Oculex Pharmaceticals, Inc.	Controlled-release biocompatible ocular drug delivery implant devices and methods
US20020090398A1 (en) *	1999-11-16	2002-07-11	Atrix Laboratories, Inc.	Biodegradable polymer composition
US20030093157A1 (en) *	2001-06-29	2003-05-15	Casares Crisoforo Peralta	Biodegradable injectable implants and related methods of manufacture and use

Also Published As

Publication number	Publication date
AU2011200355A1 (en)	2011-02-17
EP1912630A2 (fr)	2008-04-23
WO2007014210A3 (fr)	2007-10-18
CN101484145A (zh)	2009-07-15
CA2616384A1 (fr)	2007-02-01
NZ563557A (en)	2011-04-29
AU2006272663B2 (en)	2010-10-28
JP2009502928A (ja)	2009-01-29
WO2007014210A2 (fr)	2007-02-01
AU2006272663C1 (en)	2011-08-11
AU2006272663A1 (en)	2007-02-01
KR20080055782A (ko)	2008-06-19

Publication	Publication Date	Title
IL189795A0 (en)	2008-08-07	Isoindole-imide compounds and compositions comprising and methods of using the same
IL181896A0 (en)	2007-07-04	Methods and compositions for the treatment of hyperlipidemia
ZA200607433B (en)	2009-09-30	Methods and compositions for the treatment of gastroin-testinal disorders
EP1959929A4 (fr)	2012-08-15	Compositions et procedes pour le traitement de conditions dermatologiques
EP1853295A4 (fr)	2009-02-25	Procedes et compositions pour le traitement de troubles gastro-intestinaux
EP1940441A4 (fr)	2010-01-27	Compositions et methodes de traitement de troubles gastro-intestinaux
IL181543A0 (en)	2007-07-04	Dendrimer based compositions and methods of using the same
IL196465A0 (en)	2009-11-18	Compositions and methods for the treatment of mucositis
IL186963A0 (en)	2008-06-05	Methods and compositions for treating pain
IL191072A0 (en)	2008-12-29	Therapeutic compositions and methods
IL183709A0 (en)	2007-09-20	Compositions and methods for treating conditions of the nail unit
ZA200808431B (en)	2009-09-30	Fungicidal compositions and methods of using the same
EP2049151A4 (fr)	2010-03-24	Méthodes et compositions pour le traitement du cancer
ZA200800448B (en)	2012-12-27	Methods and compositions for the prevention and treatment of inflammatory disease
IL186325A0 (en)	2008-02-09	Tizanidine compositions and methods of treatment using the compositions
IL191537A0 (en)	2008-12-29	Methods and compositions for the treatment of gastrointestinal disorders
IL187405A0 (en)	2011-07-31	Methods and compositions for the treatment of pain
EP1890712A4 (fr)	2012-08-15	Compositions et methodes de traitement de la douleur
ZA200805711B (en)	2009-11-25	Solid biocidal compositions and methods of using the same
ZA200703087B (en)	2009-04-29	Methods and compositions for the treatment of hyperlipidemia
PL1791423T3 (pl)	2013-09-30	Kompozycje i sposoby postępowania z hiperproliferacyjnymi zaburzeniami dermatologicznymi
EP1912630A4 (fr)	2012-10-03	Compositions et procedes destines a reduire les douleurs postoperatoires
GB0520930D0 (en)	2005-11-23	Composition and method of use
GB0504657D0 (en)	2005-04-13	Compositions and methods of treatment
ZA200710476B (en)	2009-10-28	Methods and compositions for the treatment of pain

Legal Events

Date	Code	Title	Description
2008-03-21	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2008-04-23	17P	Request for examination filed	Effective date: 20080222
2008-04-23	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2008-04-23	AX	Request for extension of the european patent	Extension state: AL BA HR MK RS
2012-07-25	DAX	Request for extension of the european patent (deleted)
2012-10-03	A4	Supplementary search report drawn up and despatched	Effective date: 20120903
2012-10-03	RIC1	Information provided on ipc code assigned before grant	Ipc: A61F 13/00 20060101ALI20120828BHEP Ipc: A61K 31/00 20060101ALI20120828BHEP Ipc: A61K 9/22 20060101AFI20120828BHEP
2013-06-28	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2013-07-31	18D	Application deemed to be withdrawn	Effective date: 20130201